Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (34,495,505)	$ (37,610,384)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	4,106,606	6,848,193
Issuance of shares in consulting agreements	298,501	267,000
Amortization of debt discount	1,553,835	1,156,905
Loss on retirement of debt	1,107,004	0
Depreciation expense	21,836	21,112
Finance lease amortization expense	38,682	38,679
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(173,564)	(870,294)
Accounts payable	1,889,580	(5,297,956)
Accrued expenses	(2,098,987)	416,522
Operating lease liabilities	0	0
Net cash used in operating activities	(27,752,012)	(35,030,223)
Cash flows from investing activities:
Purchase of equipment	0	(29,000)
Net cash used in investing activities	0	(29,000)
Cash flows from financing activities:
Proceeds from issuance of pre-funded warrants	1,038,094	0
Proceeds from issuance of warrants	5,315,811	0
Proceeds from exercise of pre-funded warrants	100	0
Proceeds from exercise of stock options	0	774,091
Payments of finance lease obligations	(61,119)	(55,795)
Loan principal payments	(6,666,667)	(3,125,000)
Loan repayment	(19,000,000)	0
Net proceeds from issuance of loan	18,164,795	0
Proceeds from issuance of common stock, net of issuance costs	9,709,064	0
Proceeds from issuance of common stock from at-the-market program, net of issuance costs	4,274,312	22,595,001
Net cash provided by financing activities	12,774,390	20,188,297
Net (decrease) increase in cash and cash equivalents	(14,977,622)	(14,870,926)
Cash and cash equivalents at beginning of period	41,689,591	56,560,517
Cash and cash equivalents at end of period	26,711,969	41,689,591
Supplemental information of cash and non-cash transactions:
Cash paid for interest	$ 2,921,359	$ 3,556,662